Hollencrest Capital Management Mirum Pharmaceuticals, Inc. Transaction History
Hollencrest Capital Management
- $2.57 Billion
- Q3 2025
A detailed history of Hollencrest Capital Management transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Hollencrest Capital Management holds 1,888 shares of MIRM stock, worth $133,764. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,888Holding current value
$133,764% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
241Shares Held
56.2MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$481 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$371 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$229 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$196 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$187 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.6B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...